Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 2
2004 8
2005 13
2006 10
2007 21
2008 21
2009 30
2010 51
2011 56
2012 71
2013 62
2014 102
2015 114
2016 134
2017 120
2018 136
2019 184
2020 212
2021 244
2022 274
2023 251
2024 291
2025 311
2026 261

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,657 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: xu f. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses.
Sun J, Zheng W, Zhang ZG, Zhou H, Wang S, Huang D, Hu XY, Yu QF, Wu ZX, Shi YF, Ye R, Xia F, Li W, Lyu S, Huang Y, Zhang XZ, Xu F, Zhao K, Yang J, Du J, Su J, Rui Y, Xu R, Yang WM, Li C, Xu JL, Zhu R, Wang X, Wei W, Yu XF. Sun J, et al. Among authors: xu f. Signal Transduct Target Ther. 2025 Dec 15;10(1):406. doi: 10.1038/s41392-025-02523-1. Signal Transduct Target Ther. 2025. PMID: 41392286 Free PMC article.
Expert consensus on robotic radiosurgery system for hepatocellular carcinoma.
Qiu B, Jiang Y, Lian Z, Xie Y, Wei T, Ji Z, Sun H, Xu F, Peng R, Wang H, Xue J, Li G, Wu G, Wang E, Zhang H, Xu B, Liu S, Duan X, Wang J. Qiu B, et al. Among authors: xu f. J Cancer Res Ther. 2026 May 1;22(2):215-221. doi: 10.4103/jcrt.jcrt_7_25. Epub 2026 May 27. J Cancer Res Ther. 2026. PMID: 42241153 Free article.
Spatial distribution of the proteome in the human body and in cancers.
Yue L, Jiang W, Li S, Luo M, Fan N, Zhan X, Sun R, Cheng H, Xue Z, Liu T, Zhou Q, Chen K, Lu T, Guo F, Li D, Ge W, Nie Z, Lyu M, A J, Wang Y, Chen Y, Fu Z, Xiang N, Li L, Yu F, Teo GC, Nesvizhskii AI, Wang M, Snyder MP, Collins BC, Xiao Q, Aebersold R, Xu F, Yang H, Zhang S, Han Y, Zhu Y, Ji Y, Li Y, Guo T. Yue L, et al. Among authors: xu f. Nature. 2026 Aug;656(8126):227-236. doi: 10.1038/s41586-026-10660-y. Epub 2026 Jun 17. Nature. 2026. PMID: 42310461 Free PMC article.
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study.
Xu JF, Zheng HZ, Lu HW, Wang LW, Wu B, Lv XD, Luo H, Feng J, Li YY, Liu L, Jia JG, Mo WQ, Gu HY, Jiang JB, Wang DX, Wang B, Li L, Yuan Z, Li W, Xie M, Jie ZJ, Fan XY, Li D, Tian X, Zhang M, Guan WJ, Fan H, Song YL, He J, Chu DJ, Du CL, Zhang JQ, Cao C, Qu JM, Chalmers JD; BE-China Registry Investigators. Xu JF, et al. Lancet Respir Med. 2025 Feb;13(2):166-176. doi: 10.1016/S2213-2600(24)00364-3. Epub 2025 Jan 10. Lancet Respir Med. 2025. PMID: 39805296 Free article.
2,657 results